Achieving Efficient Sensitive Rare Cell Capture Culture Downstream Molecular Analyses @BioRadLaboratoriesCorp
Achieving Efficient Sensitive Rare Cell Capture Culture Downstream Molecular Analyses  @BioRadLaboratoriesCorp
Uploaded July 2023 | Updated September 2026, 2 weeks ago
Characterization of rare cells remains a major challenge for the evaluation and understanding of key biological systems, such as circulating tumor cells (CTCs) from liquid biopsy, stem cells and CRISPR gene-edited cells. In this webinar, a novel integrated workflow utilizing the Genesis Cell Isolation System with Celselect slide technology is presented that provides efficiency and versatility for performing cell capture, enumeration and cell recovery. Immuno-labeling and staining of captured cells can be performed on-slide directly, or alternatively, live cells can be recovered and either cultured or interrogated further using a variety of downstream molecular applications. This presentation focuses on the utility of rapid, efficient capture and recovery of rare cells from a model system. Gentle size-based cell isolation allows retention of native biology, an important consideration for downstream applications such as gene expression analyses by qPCR and RNA sequencing, and easily lends samples to mutation detection by digital PCR.

Learn more about Genesis Cell Isolation System with Celselect slide technology: bio-rad.com/en-us/category/cell-capture-recovery?ID=3b7d67be-8213-ed2f-0b0a-1ee1f456f801&?WT.mc_id=230725038521

Subscribe to the Bio-Rad channel: youtube.com/user/BioRadLifeScience?sub_confirmation=1

We Are Bio-Rad.

Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.

Connect with Bio-Rad Online:
Website: bio-rad.com/genomics-solutions
LinkedIn: linkedin.com/company/bio-rad
Facebook: facebook.com/BioRadGenomics
Twitter: twitter.com/BioRadGenomics
Instagram: instagram.com/bioradlabs

©2023 Bio-Rad is a trademark of Bio-Rad Laboratories, Inc. in certain jurisdictions. All trademarks used herein are the property of their respective owner.

Music used by permission granted by royalty-free license from Pond5.com
Achieving Efficient Sensitive Rare Cell Capture Culture Downstream Molecular AnalysesBCR-ABL1 TKD Mutation Testing using ddPCR in a Clinical Hematology Laboratory Q&A: Part 3Bio-Rad ddSEQ Single-Cell 3 RNA-Seq KitBio-Plex SARS-CoV-2 Neutralization Antibody Assays WebinarBCR-ABL1 TKD Mutation Testing using ddPCR in a Clinical Hematology Laboratory Q&A: Part 4ddPCR Is Critical for Oncology Research At Biodesix2023 Positive Droplet Award Acceptance, Molecular Analytical Development, Dr. Deendayal Patel, PhDEnhancing Process Dev with Viral Clearance: mAb Purification w/ a Weak AEX-HIC Chromatography Resin2022 Positive Droplet Award, Respiratory Disease, Raphael Nyaruaba, PhDConversations with Customers Interview: PIF Supplement User, Oceania Dairy Limited, New ZealandQuick Tips: Western Blot Transfer of High MW Proteins using Trans Blot Turbo Transfer SystemIn the Lab with Anthony: Using the PIF Supplement for Infant Formula Testing
Bio-Rad Laboratories |

Achieving Efficient Sensitive Rare Cell Capture Culture Downstream Molecular Analyses

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER